STSS Stock Overview
A medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Sharps Technology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.53 |
| 52 Week High | US$18.15 |
| 52 Week Low | US$2.34 |
| Beta | 1.19 |
| 11 Month Change | 21.72% |
| 3 Month Change | -37.08% |
| 1 Year Change | -63.76% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -92.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| STSS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 25.6% | 1.7% | 0.3% |
| 1Y | -63.8% | 21.4% | 31.1% |
Return vs Industry: STSS underperformed the US Medical Equipment industry which returned 20.3% over the past year.
Return vs Market: STSS underperformed the US Market which returned 30.3% over the past year.
Price Volatility
| STSS volatility | |
|---|---|
| STSS Average Weekly Movement | 15.8% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: STSS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: STSS's weekly volatility has decreased from 25% to 16% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 57 | Robert Hayes | sharpstechnology.com |
Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.
Sharps Technology, Inc. Fundamentals Summary
| STSS fundamental statistics | |
|---|---|
| Market cap | US$5.81m |
| Earnings (TTM) | -US$7.87m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.8x
P/E RatioIs STSS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STSS income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$7.87m |
| Earnings | -US$7.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.38 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did STSS perform over the long term?
See historical performance and comparison